{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:45:45Z","timestamp":1784972745078,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1687,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Korea Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean Government","award":["KRF-20100008732"],"award-info":[{"award-number":["KRF-20100008732"]}]}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ajpath.2015.01.021","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T07:30:03Z","timestamp":1426318203000},"page":"1423-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome"],"prefix":"10.1016","volume":"185","author":[{"given":"Eun Hui","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Konvalinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Maksimowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Scholey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.01.021_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary Familial Congenital Haemorrhagic Nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"Br Med J"},{"key":"10.1016\/j.ajpath.2015.01.021_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","article-title":"Genetics of classic Alport's syndrome","volume":"2","author":"Flinter","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2015.01.021_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s004670050451","article-title":"Chronology of renal scarring in males with Alport syndrome","volume":"12","author":"Kashtan","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib4","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1016\/S0021-9258(19)74270-7","article-title":"Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis","volume":"268","author":"Hudson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.01.021_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0272-6386(99)70385-9","article-title":"ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy","volume":"34","author":"Remuzzi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajpath.2015.01.021_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00467-012-2372-9","article-title":"Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome","volume":"28","author":"Webb","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib7","doi-asserted-by":"crossref","first-page":"e71433","DOI":"10.1371\/journal.pone.0071433","article-title":"Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.01.021_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/labinvest.2012.2","article-title":"Loss of angiotensin-converting enzyme 2 enhances TGF-beta\/Smad-mediated renal fibrosis and NF-kappaB-driven renal inflammation in a mouse model of obstructive nephropathy","volume":"92","author":"Liu","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2015.01.021_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2015.01.021_bib10","doi-asserted-by":"crossref","first-page":"24834","DOI":"10.1074\/jbc.M113.485326","article-title":"Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)","volume":"288","author":"Konvalinka","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.01.021_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.ki.5000011","article-title":"Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms","volume":"69","author":"Huang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI21398","article-title":"Inhibition of diabetic nephropathy by a decoy peptide corresponding to the \u201chandle\u201d region for nonproteolytic activation of prorenin","volume":"114","author":"Ichihara","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.01.021_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.ki.5002408","article-title":"Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats","volume":"72","author":"Krebs","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ki.5000210","article-title":"RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney","volume":"69","author":"Sachetelli","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/sj.ki.5002188","article-title":"Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice","volume":"71","author":"Brezniceanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ki.2010.63","article-title":"Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice","volume":"77","author":"Godin","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1681\/ASN.2004030222","article-title":"Albumin activates ERK via EGF receptor in human renal epithelial cells","volume":"16","author":"Reich","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib18","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/endo.143.8.8931","article-title":"High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells","volume":"143","author":"Hsieh","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2015.01.021_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2011121159","article-title":"Liver angiotensinogen is the primary source of renal angiotensin II","volume":"23","author":"Matsusaka","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib20","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.01.021_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2015.01.021_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","article-title":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway","volume":"172","author":"Koka","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2015.01.021_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.2013.193","article-title":"Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats","volume":"84","author":"Ali","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib27","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib28","doi-asserted-by":"crossref","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","article-title":"Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease","volume":"298","author":"Dilauro","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib30","doi-asserted-by":"crossref","first-page":"e37649","DOI":"10.1371\/journal.pone.0037649","article-title":"Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.01.021_bib31","doi-asserted-by":"crossref","first-page":"F600","DOI":"10.1152\/ajprenal.00600.2012","article-title":"Regulation of urinary ACE2 in diabetic mice","volume":"305","author":"Wysocki","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00138-5","article-title":"Angiotensin-(1-7): an update","volume":"91","author":"Santos","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.ajpath.2015.01.021_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.15.2512","article-title":"Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis","volume":"15","author":"Vilas-Boas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2015.01.021_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcm.2006.11.002","article-title":"AT(1) receptors and control of blood pressure: the kidney and more","volume":"17","author":"Crowley","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2015.01.021_bib35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","author":"Pinheiro","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1523-1755.2000.00150.x","article-title":"Angiotensin II induces renal oxidant stress in\u00a0vivo and heme oxygenase-1 in\u00a0vivo and in\u00a0vitro","volume":"58","author":"Haugen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2015.01.021_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.HYP.35.3.800","article-title":"Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection","volume":"35","author":"Aizawa","year":"2000","journal-title":"Hypertension"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:08:12Z","timestamp":1651518492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944015000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0002944015000905"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.01.021","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}